Additional information
White Powder
16684-06-3
ACI-031703
131.7-132.5°C
C18H33ClN2O5S
424.98
Ambient
2-8°C
Antibiotic
Pharmaceutical Impurity Standards
Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-[[[2S,4R)-1-methyl,)-4-propyl-L-2-pyrrolidinyl] carbonyl]amino]-1-thio-D-erythro-a-D-galacto-octopyranoside Hydrochloride (7-Epi Clindamycin hydrochloride)
(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-?-D-galacto-octopyranoside;





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)